Finance

Beta
Lists
CRTX:LON
CRISM' Therapeutics Corp
GBX 9.90
+1.54%
(+0.15) 1D
Jul 1, 11:03:57 AM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for CRTX...
Open
GBX 9.00
High
GBX 10.00
Low
GBX 9.00
Mkt. cap
7.84M
Avg. vol.
231.36K
Volume
48.00K
52-wk high
GBX 18.50
52-wk low
GBX 8.00
EPS
-GBX 0.05
Shares outstanding
79.19M
No. of employees
0
Open
GBX 9.00
High
GBX 10.00
Low
GBX 9.00
Mkt. cap
7.84M
Avg. vol.
231.36K
Volume
48.00K
52-wk high
GBX 18.50
52-wk low
GBX 8.00
EPS
-GBX 0.05
Shares outstanding
79.19M
No. of employees
0
News stories
From sources across the web
About CRISM' Therapeutics Corp
CEO-
Employees0
Founded2016
Headquarters-
SectorBiotechnology
Previous reports
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
115.50K
115.50K
Cost of goods sold
1.50K
1.50K
48.50K
48.50K
Cost of revenue
1.50K
1.50K
48.50K
48.50K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
452.50K
452.50K
552.00K
552.00K
Operating expense
452.50K
452.50K
552.00K
552.00K
Total operating expenses
454.00K
454.00K
600.50K
600.50K
Operating income
-454.00K
-454.00K
-485.00K
-485.00K
Other non operating income
-
-
-
-
EBT including unusual items
-454.00K
-454.00K
-485.00K
-485.00K
EBT excluding unusual items
-454.00K
-454.00K
-485.00K
-485.00K
Income tax expense
-
-
-1.00K
-1.00K
Effective tax rate
-
-
0.21%
0.21%
Other operating expenses
-
-
-
-
Net income
-465.00K
-465.00K
-486.50K
-486.50K
Net profit margin
-
-
-421.21%
-421.21%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-450.00K
-450.00K
-480.50K
-480.50K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more